Fabrication of an antibody-aptamer sandwich assay for electrochemical evaluation of levels of β-amyloid oligomers

[1]  Ning Xia,et al.  Visual and fluorescent assays for selective detection of beta-amyloid oligomers based on the inner filter effect of gold nanoparticles on the fluorescence of CdTe quantum dots. , 2016, Biosensors & bioelectronics.

[2]  A. Sun,et al.  A spiropyran-based fluorescent probe for the specific detection of β-amyloid peptide oligomers in Alzheimer's disease. , 2016, Chemical communications.

[3]  T. Tokuda,et al.  Monoclonal antibody with conformational specificity for a toxic conformer of amyloid β42 and its application toward the Alzheimer’s disease diagnosis , 2016, Scientific Reports.

[4]  J. Kang,et al.  Droplet-based magnetic bead immunoassay using microchannel-connected multiwell plates (μCHAMPs) for the detection of amyloid beta oligomers. , 2016, Lab on a chip.

[5]  Zhiai Xu,et al.  Selective amyloid β oligomer assay based on abasic site-containing molecular beacon and enzyme-free amplification. , 2016, Biosensors & bioelectronics.

[6]  Yanli Zhou,et al.  Detection of Aβ Monomers and Oligomers: Early Diagnosis of Alzheimer's Disease. , 2016, Chemistry, an Asian journal.

[7]  Yanli Zhou,et al.  Detection of Aβ Monomers and Oligomers: Early Diagnosis of Alzheimer's Disease. , 2016, Chemistry, an Asian journal.

[8]  Jianxiu Wang,et al.  Surface plasmon resonance biosensors for simultaneous monitoring of amyloid-beta oligomers and fibrils and screening of select modulators. , 2016, The Analyst.

[9]  L. Tjernberg,et al.  Highly Sensitive FRET-FCS Detects Amyloid β-Peptide Oligomers in Solution at Physiological Concentrations. , 2015, Analytical chemistry.

[10]  Ning Xia,et al.  A graphene oxide-based fluorescent platform for selective detection of amyloid-β oligomers , 2015 .

[11]  C. L. Teoh,et al.  Chemical Fluorescent Probe for Detection of Aβ Oligomers. , 2015, Journal of the American Chemical Society.

[12]  J. Kang,et al.  Magnetic bead droplet immunoassay of oligomer amyloid β for the diagnosis of Alzheimer's disease using micro-pillars to enhance the stability of the oil-water interface. , 2015, Biosensors & bioelectronics.

[13]  Yanli Zhou,et al.  Simple Colorimetric Detection of Amyloid β-peptide (1-40) based on Aggregation of Gold Nanoparticles in the Presence of Copper Ions. , 2015, Small.

[14]  G. Shi,et al.  A method for evaluating the level of soluble β-amyloid(1-40/1-42) in Alzheimer's disease based on the binding of gelsolin to β-amyloid peptides. , 2014, Angewandte Chemie.

[15]  David J Hayne,et al.  Metal complexes designed to bind to amyloid-β for the diagnosis and treatment of Alzheimer's disease. , 2014, Chemical Society reviews.

[16]  N. Hooper,et al.  A label-free electrical impedimetric biosensor for the specific detection of Alzheimer's amyloid-beta oligomers. , 2014, Biosensors & bioelectronics.

[17]  Nan Li,et al.  Electrochemical immunosensors for effective evaluation of amyloid-beta modulators on oligomeric and fibrillar aggregation processes. , 2014, Analytical chemistry.

[18]  Ning Xia,et al.  Competitive electrochemical immunoassay for detection of β-amyloid (1-42) and total β-amyloid peptides using p-aminophenol redox cycling. , 2014, Biosensors & bioelectronics.

[19]  B. Hyman,et al.  A Luminex Assay Detects Amyloid β Oligomers in Alzheimer’s Disease Cerebrospinal Fluid , 2013, PloS one.

[20]  M. Verbeek,et al.  Amyloid-β oligomer detection by ELISA in cerebrospinal fluid and brain tissue. , 2013, Analytical biochemistry.

[21]  Hao Li,et al.  A general way to assay protein by coupling peptide with signal reporter via supermolecule formation. , 2013, Analytical chemistry.

[22]  E. Matveeva,et al.  Structure-selective anisotropy assay for amyloid Beta oligomers. , 2012, ACS chemical neuroscience.

[23]  J. H. Viles,et al.  Metal ions and amyloid fiber formation in neurodegenerative diseases. Copper, zinc and iron in Alzheimer's, Parkinson's and prion diseases , 2012 .

[24]  I. Hamley.  The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization. , 2012, Chemical reviews.

[25]  K. Reymann,et al.  Molecular basis of β-amyloid oligomer recognition with a conformational antibody fragment , 2012, Proceedings of the National Academy of Sciences.

[26]  K. P. Kepp,et al.  Bioinorganic chemistry of Alzheimer's disease. , 2012, Chemical reviews.

[27]  K. Ikebukuro,et al.  Selection of DNA aptamers that recognize α-synuclein oligomers using a competitive screening method. , 2012, Analytical chemistry.

[28]  M. Göbel,et al.  Laser-induced liquid bead ion desorption mass spectrometry: an approach to precisely monitor the oligomerization of the β-amyloid peptide. , 2012, Analytical chemistry.

[29]  Weian Zhao,et al.  Colorimetric and ultrasensitive bioassay based on a dual-amplification system using aptamer and DNAzyme. , 2012, Analytical chemistry.

[30]  T. Rosenberry,et al.  A mass spectrometric approach for characterization of amyloid-β aggregates and identification of their post-translational modifications. , 2012, Biochemistry.

[31]  H. Mihara,et al.  FRET detection of amyloid β-peptide oligomerization using a fluorescent protein probe presenting a pseudo-amyloid structure. , 2012, Chemical communications.

[32]  T. Tokuda,et al.  High-molecular weight β-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients , 2010, Alzheimer's & Dementia.

[33]  Yuehe Lin,et al.  Aptamer/graphene oxide nanocomplex for in situ molecular probing in living cells. , 2010, Journal of the American Chemical Society.

[34]  A. Rauk.  The chemistry of Alzheimer's disease. , 2009, Chemical Society reviews.

[35]  Jiri Homola,et al.  Surface plasmon resonance biosensors for detection of Alzheimer disease biomarker , 2009 .

[36]  R. V. Van Duyne,et al.  Detection of a biomarker for Alzheimer's disease from synthetic and clinical samples using a nanoscale optical biosensor. , 2005, Journal of the American Chemical Society.

[37]  Jinghong Li,et al.  Electrochemical detection of DNA immobilized on gold colloid particles modified self-assembled monolayer electrode with silver nanoparticle label. , 2003, Journal of pharmaceutical and biomedical analysis.

[38]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[39]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[40]  F Chollet,et al.  [Early diagnosis of Alzheimer's disease]. , 2012, Revue neurologique.

[41]  Lance Lewand,et al.  Chemist's Perspective , 2005 .